An experimental new treatment is showing early promise in the fight against liver fibrosis – a serious and often silent ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...

Roche is rolling out a new diagnostic test to help assess hidden liver fibrosis in patients showing signs of metabolic ...

A major international study has found that semaglutide, a drug already used to treat type 2 diabetes and obesity, can ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

Researchers from the Karolinska Institutet in Sweden have found a potential new treatment for non-alcoholic fatty liver ...

The weight loss drug Wegovy treated a serious form of liver disease in about two-thirds of patients in a major clinical trial ...

Anti-aging biotech NewLimit plans to push a liver-rejuvenating mRNA medicine into the clinic with the aid of a ...

Liver disease encompasses a range of conditions that affect the liver, an essential organ involved in digestion, metabolism, and ridding the body of toxins. Common symptoms of liver disease ...

Metabolic liver disease might not get as much attention as heart disease or diabetes, but it affects around one in four ...